Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Microsoft, Chipotle, Intuitive Surgical

Wed, 22nd Jul 2015 14:25

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks fell in early trading on Wednesday afterdisappointing results from technology giants including Apple,the world's largest publicly traded company. The Dow Jonesindustrial average was down 0.12 percent at 17,897.7, theS&P 500 was down 0.10 percent at 2,116.99 and the NasdaqComposite was down 0.58 percent at 5,177.793.

** APPLE INC, $124.41, -4.85 pct

The company's fourth-quarter revenue forecast fell short ofestimates and it missed some targets for iPhone sales. Theforecast overshadowed Apple's strong sales in China, which morethan doubled to $13.23 billion from a year earlier.

** CHIPOTLE MEXICAN GRILL INC, $724.64, +7.66 pct

The Burrito chain reported a better-than-expected quarterlyprofit as margins rose due to lower ingredient costs. Piper Jaffray, JP Morgan raised price targets.

** INTUITIVE SURGICAL INC, $560.36, +10.94 pct

The robotic surgical equipment maker reported abetter-than-expected quarterly profit and forecast surgicalprocedures to grow 11 to 13 percent this year, sending itsshares up 13 percent.

** BIOGEN, $397.09, -3.03 pct

A 6 mg dose of the drugmaker's experimental Alzheimer'sdisease drug significantly reduced beta amyloid plaque in thebrain but failed to significantly slow mental decline,potentially tempering great enthusiasm that greeted data on twoother doses of the treatment earlier this year.

** XOMA CORP, $1.0788, -75.45 pct

The drug developer says its experimental treatment for aninflammatory disease failed to meet main goal of late-stagestudy. The company says the compound, gevokizumab, was notbetter than a placebo in reducing risk of inflammation inpatients's blood vessels in the eye.

** ABBOTT LABORATORIES INC, $50.9, +2.29 pct

The company reported a slightly better-than-expectedquarterly profit, helped by higher sales of its brandedgenerics.

** LIPOCINE INC, $13.04, +10.60 pct

Analysts at Roth Capital start coverage of the drugmaker'sstock with "buy" rating. We believe Lipocine's LPCN 1021, whichis an oral T formulation, is on track to become the firstlandmark product in the category since the popular Androdermgel's launch in 2000", analysts say.

** MICROSOFT CORP, $46.1801, -2.33 pct

The company reported a $3.2 billion quarterly net loss, itsbiggest ever, as the company wrote down its Nokia phone businessand demand fell for its Windows operating system. The companytook a charge of $7.5 billion in the fourth quarter related tothe restructuring of its Nokia handset business, which it boughtlast year.

** YAHOO INC, $39.07, -1.66 pct

The company forecast lower-than-expected revenue for thecurrent quarter as it struggles to revive its core onlineadvertising business and spends more to attract users to itswebsites.

** REGULUS THERAPEUTICS INC, $9.57, -6.27 pct

Sources cite UBS reoffering 2.33 mln shares versus stock's$10.21 close; expected price and seller(s) not known.

** BOEING CO, $147.92, +2.01 pct

Boeing Co BA.N topped earnings estimates and doubled itsclosely watched quarterly cash flow, partly offsetting a bigcharge for its aerial tanker program.

** THORATEC CORP, $63.07, +9.53 pct

** ST JUDE MEDICAL INC, $77.26, +0.72 pct

Medical device maker St Jude Medical agreed to buy smallerrival Thoratec Corp for about $3.4 billion to expand itsportfolio of heart failure devices.

** AUTONATION, $62.56, -3.34 pct

The largest U.S. auto retailer, reported a 15 percent risein quarterly profit as an improving economy and low oil pricesboosted vehicle sales.

** BHP BILLITON, $38.29, -3.50 pct

** CLIFFS NATURAL RESOURCES INC, $2.56, -12.33 pct

London copper at two-week lows, Chinese steel &iron ore futures fall as demand weakens.

All four of BHP's "four pillars of growth" currently atmulti-year lows and forward price curves charted by Reuterssuggest that is unlikely to change soon. The world's biggestminer has 10 major commodities, including iron ore, copper,petroleum products and coal.

** THERMO FISHER SCIENTIFIC INC, $139.84, +2.47 pct

The world's largest maker of scientific instruments reporteda better-than-expected quarterly profit, helped by lower costsand strength in its life sciences unit.

** INTERPUBLIC GROUP OF COS INC, $20.4, +3.03 pct

The Advertising company's second-quarter revenue trumpedexpectations for the seventh straight quarter as higheradvertising spending by U.S. businesses made up for the strongdollar's impact on international revenue. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.